4//SEC Filing
During Matthew 4
Accession 0001209191-19-013904
CIK 0001636651other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:42 PM ET
Size
5.5 KB
Accession
0001209191-19-013904
Insider Transaction Report
Form 4
During Matthew
DirectorPresident and CSO10% Owner
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-02-24+70,000→ 70,000 totalExercise: $1.89Exp: 2029-02-23→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001704631
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 9:42 PM ET
- Size
- 5.5 KB